Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study

OBJECTIVE: Insulin pump therapy (continuous subcutaneous insulin infusion [CSII]) and multiple daily injections (MDIs) with insulin glargine as basal insulin and mealtime insulin lispro have not been prospectively compared in people naïve to either regimen in a multicenter study. We aimed to help cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolli, Geremia B., Kerr, David, Thomas, Reena, Torlone, Elisabetta, Sola-Gazagnes, Agnès, Vitacolonna, Ester, Selam, Jean Louis, Home, Philip D.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699706/
https://www.ncbi.nlm.nih.gov/pubmed/19389820
http://dx.doi.org/10.2337/dc08-1874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699706/
https://www.ncbi.nlm.nih.gov/pubmed/19389820
http://dx.doi.org/10.2337/dc08-1874

Ejemplares similares